Summary
A landmark JAMA study found remote cognitive behavioral therapy (CBT) programs—delivered via telehealth coaching or self-guided online modules—significantly reduced pain severity and interference in patients with high-impact chronic pain compared to usual care. At 3 months, 32% in the coach-led group and 27% in the online group achieved ≥30% pain reduction versus 21% in controls, with benefits sustained through 12 months across pain, function, and quality-of-life measures. These scalable interventions address accessibility barriers for first-line nonpharmacologic treatment amid the opioid epidemic.
Key Takeaways
- Remote CBT programs achieved 26-32% pain reduction rates at 3 months vs. 21% for usual care, sustained to 12 months.
- Health coach-led telehealth slightly outperformed self-guided online CBT, especially short-term.
- CBT targets pain interference by reframing thoughts, improving function and quality of life without drugs.
- Study highlights scalability to address first-line nonpharmacologic treatment access barriers.
- Findings from 2,331 participants support integration into health systems amid opioid crisis.
Balanced Perspective
The RESOLVE trial randomized 2,331 adults with high-impact chronic pain to telehealth CBT, online self-guided CBT, or usual care, measuring outcomes like pain severity via Brief Pain Inventory at 3, 6, and 12 months. Both interventions outperformed usual care on primary (≥30% pain reduction) and secondary endpoints, with coach-led slightly edging online at 3 months, though all gains were described as modest. Long-term data confirms durability, but generalizability depends on diverse populations and real-world implementation beyond controlled settings.
Optimistic View
This breakthrough validates CBT as a game-changer for chronic pain management, proving remote delivery matches in-person efficacy while slashing costs and wait times. With 32% of coached participants hitting clinically meaningful pain relief and effects lasting a year, health systems can now deploy these tools at scale, empowering millions to reclaim daily function without opioids. Widespread adoption could slash healthcare burdens, boost productivity, and spark a new era of accessible mental health integration in pain care.
Critical View
While statistically significant, the 'modest' improvements—32% response rate in the best arm—leave most patients (68%) without meaningful relief, underscoring CBT's limitations for severe cases unresponsive to prior treatments. Scalability risks subpar adherence in self-guided formats without coach support, and overhyping could divert resources from emerging biologics or neuromodulation. Equity gaps persist: digital divides and low health literacy may exclude vulnerable groups, perpetuating pain disparities in under-resourced communities.
Source
Originally reported by usnews.com